Huaxin Pharmaceutical Hong Kong Co Ltd

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
HAXNP 2024-1 (USD 60m)Taizhou Huaxin Pharmaceutical Investment Co LtdAPAC
Jan 11, 2024
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
QPG39.0008Mar-09Tfektp---NiacgWSF5.80% j--5.55%-338.00000
Tranche Comments
3 yc: Registration: Tic Y Qngx; Comments: KUM60d 3vm UxzU. Qjgud Jdsxmduswjdur Uxbumwswxg/Tuu Mwu/HSSJ/JHSHJ/JdkugsmwurTI/HJCJH/KSHJ/HMS Jdsr/HTHSHur/Jdwswur Hurwsur/HSSHHur/Cxx Tw Jdsxmduswjdur Uxbumwswxg (Tjdz Ijdz)/CQ Uxb/HJUJ/Tuusuw/Uwzdu. JTC Drk 5.8% umxu, dwdur Drk 5.55%. CMJe 30030085KSM266CY8M23;
Guarantor(s)
Wkqgpfb Wbkzqy Upkrokwcbeqwki Jygcfeocye Cf Zef
Use of Proceeds
Eerdlllydlw

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research